ALSO NOTED: Sanofi sues to fight off Uroxatral imitators; Watson gets OK for generic AccuNeb

> Sanofi Aventis sued two generics makers--Teva Pharmaceuticals and Barr Laboratories--for infringing its patents on the prostate cancer drug Uroxatral. Report [1]

> Watson Pharmaceuticals got the FDA nod for its generic form of the asthma medication AccuNeb. Report [2]

> Sanofi Pasteur is scouting India, among other countries, for possible locations for a global manufacturing base, the Economic Times reports. Report [3]

[3]> AstraZeneca is poised to open an Israeli office and is seeking a local general manager there.  Report [4]

And Finally... Don't count on snagging your daily meds from a pharma facility. The thieves who got out of Genentech with human growth hormone are exceptions to the high-security rule--so much so that one expert likened a drug-company theft to stealing gold from Fort Knox. Report [5]